Growing evidence supporting the use of mesenchymal stem cell therapies in multiple sclerosis: a systematic review

ConclusionsMSCs transplantation proved to be a safe and tolerable therapy. Their potential therapeutic benefits were also validated. However, larger placebo controlled blinded clinical trials will be required to establish the long term safety and efficacy profile of these therapies for MS. Their translation into the clinical practice can provide a new hope for the patients of this highly debilitating disease.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research